Thanks to the meteoric rise of digital health, the role of data and analytics has also become central across the drug development life cycle, impacting every touch point from pipeline research and development to clinical trial design and implementation. A critical area that has fallen short, however, is applying a commensurate level of enthusiasm and expense for market research in the early phase as that afforded to downstream commercialization efforts. Compounding this challenge is the continued marginalization of disenfranchised communities.
CAR T therapies have revolutionized oncology patient care. But to ensure the often lifesaving benefits of these therapies reach the right patients, life sciences companies must navigate complex decision-making and treatment processes to maximize uptake.
Lumanity today announced the acquisition of Endpoint Outcomes, a company specializing in harnessing the voice of patients to document the impact of treatments on health-related quality of life. Lumanity CEO Jon Williams says, “We look forward to working with our new colleagues to define and build market-leading, patient-centered research services to address both HTA and payer needs, and we are confident that our work will yield innovative new solutions for our clients and partners.”
WPP company CMI Media Group and NMSDC certified diverse supplier Compas announce continued investment in building real solutions for client challenges and opportunities with the launch of a Technology and Data business unit that flexibly works to provide clients solutions the way they want, including turnkey access to some of the agencies’ proprietary platforms.
Rune Labs on Monday said the San Francisco-based startup has received clearance from the U.S. Food and Drug Administration to use the Apple Watch to monitor tremors and other common symptoms in patients with Parkinson’s disease.
Med Ad News caught up with Fishawack Health CEO Jon Koch and Avalere Health President Elizabeth Carpenter to discuss the deal and why it took place, and what Avalere brings to Fishawack.
CMI Media Group, a leading media agency to healthcare’s game changers and a WPP company, on Monday celebrated the 10th anniversary of the industry-changing platform, Empower™. According to CMI Media Group, this is the industry’s first and only people-first precision and performance data platform that manages the complete marketing process. From insights to planning and media activation to optimization, Empower™ leverages consistent healthcare audience data.
The number of births in the United States grew 1% in 2021 from a pandemic low in 2020, marking the first increase since 2014, according to a report by the U.S. Centers for Disease Control and Prevention (CDC).
imre put a stake in the ground to be a leading data-driven marketing agency by naming Matthew Zogby as Chief Data Officer. Zogby’s hire coincides with the addition of Christopher Lang as Head of Data Science, as the pair sets out how to redefine what data means to the agency and how data shows up for client partners.